Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 61.90%34M | -19.25%365M | 12.57%627M | 37.20%1.54B | 229.87%508M | 600.00%21M | 21.18%452M | -5.75%557M | 107.98%1.12B | 153.47%154M |
| Net income from continuing operations | -182.35%-14M | 635.29%182M | -3.85%400M | -11.76%608M | 63.28%209M | 143.59%17M | -123.61%-34M | -8.77%416M | 20.24%689M | 93.94%128M |
| Operating gains losses | 114.49%10M | -316.22%-160M | 24.18%-116M | 40.27%-178M | -139.73%-29M | -195.83%-69M | 144.05%74M | 44.16%-153M | -2,192.31%-298M | -48.59%73M |
| Depreciation and amortization | 5.04%125M | 7.69%126M | 10.34%128M | 7.71%475M | 11.82%123M | 9.17%119M | 4.46%117M | 4.50%116M | 0.46%441M | -1.79%110M |
| Remuneration paid in stock | -33.33%4M | -20.00%4M | 60.00%16M | 120.83%53M | 255.56%32M | 500.00%6M | 66.67%5M | -9.09%10M | -25.00%24M | -30.77%9M |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -66.67%1M | ---- |
| Deferred tax | -44.44%-13M | 347.06%42M | -19.39%79M | -46.11%97M | 13.64%25M | -80.00%-9M | -132.69%-17M | -10.91%98M | 50.00%180M | 15.79%22M |
| Other non cashItems | -58.82%7M | -18.18%9M | 425.00%13M | 186.21%25M | -66.67%2M | 221.43%17M | 320.00%11M | 75.00%-4M | -238.10%-29M | -25.00%6M |
| Change In working capital | -65.63%-106M | -51.37%142M | 22.54%87M | 330.00%430M | 165.15%129M | 48.39%-64M | 26.41%292M | -62.63%71M | 115.38%100M | 69.68%-198M |
| -Change in receivables | -9.38%29M | -5.05%376M | -219.44%-43M | -25.83%201M | 0.38%-265M | 111.72%32M | -3.88%396M | -90.93%36M | 139.22%271M | 60.18%-266M |
| -Change in inventory | -821.43%-101M | 45.33%-82M | -47.04%161M | -31.82%165M | 0.00%-3M | 114.00%14M | -7,400.00%-150M | -12.39%304M | 174.69%242M | -103.09%-3M |
| -Change in prepaid assets | -200.00%-18M | -42.55%27M | 172.73%16M | 500.00%4M | -50.00%-39M | 38.46%18M | 213.33%47M | -633.33%-22M | 0.00%-1M | 64.86%-26M |
| -Change in payables and accrued expense | 129.91%32M | -2,516.67%-145M | 43.20%-117M | 143.82%78M | 226.27%385M | -140.07%-107M | 103.03%6M | 43.56%-206M | -147.21%-178M | -47.32%118M |
| -Change in other current assets | -140.00%-2M | 466.67%22M | 122.73%49M | 124.29%17M | 80.00%-4M | 117.86%5M | -115.79%-6M | 136.67%22M | -511.76%-70M | -322.22%-20M |
| -Change in other current liabilities | 353.85%59M | -145.45%-54M | -3.64%-57M | 133.33%36M | 108.33%100M | 8.33%13M | -10.00%-22M | 62.84%-55M | -235.00%-108M | -55.56%48M |
| -Change in other working capital | -169.23%-105M | -109.52%-2M | 1,075.00%78M | -26.79%-71M | 8.16%-45M | -160.00%-39M | 250.00%21M | -136.36%-8M | 48.15%-56M | 85.96%-49M |
| Dividends received (cash flow from operating activities) | 425.00%21M | 400.00%20M | 566.67%20M | 115.38%28M | 466.67%17M | 33.33%4M | 0.00%4M | 0.00%3M | -7.14%13M | 0.00%3M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 61.90%34M | -19.25%365M | 12.57%627M | 37.20%1.54B | 229.87%508M | 600.00%21M | 21.18%452M | -5.75%557M | 107.98%1.12B | 153.47%154M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -8.14%-425M | -17.05%-357M | -28.00%-352M | -590.95%-1.38B | 32.32%-402M | -61.73%-393M | -32.03%-305M | -131.65%-275M | 80.04%-199M | -76.79%-594M |
| Capital expenditure reported | -3.69%-422M | -16.72%-356M | -27.17%-351M | -47.30%-1.39B | -49.63%-401M | -66.80%-407M | -32.61%-305M | -37.31%-276M | 1.57%-943M | 20.00%-268M |
| Net business purchase and sale | -121.43%-3M | 0.00%-1M | ---1M | 103.64%12M | 99.69%-1M | --14M | 0.00%-1M | --0 | -15.79%-330M | ---327M |
| Net other investing changes | ---- | ---- | ---- | -99.81%2M | --0 | ---- | --1M | -99.91%1M | 338.37%1.07B | --1M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -8.14%-425M | -17.05%-357M | -28.00%-352M | -590.95%-1.38B | 32.32%-402M | -61.73%-393M | -32.03%-305M | -131.65%-275M | 80.04%-199M | -76.79%-594M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -82.77%189M | 156.44%114M | 40.79%-164M | 80.16%-175M | -261.18%-793M | 403.21%1.1B | -23.93%-202M | 80.62%-277M | -302.76%-882M | -8.72%492M |
| Net issuance payments of debt | 337.84%176M | 193.62%132M | 14.87%-166M | 131.72%46M | -40.99%455M | -124.03%-74M | -88.00%-141M | 83.03%-195M | -110.80%-145M | 22.77%771M |
| Net preferred stock issuance | ---200M | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 65.16%-200M | ---- |
| Cash dividends paid | -5.32%-99M | -8.70%-100M | -7.61%-99M | -8.16%-371M | -8.14%-93M | -9.30%-94M | -6.98%-92M | -8.24%-92M | -1.48%-343M | -4.88%-86M |
| Proceeds from stock option exercised by employees | -40.00%6M | -76.00%6M | 5.88%18M | 217.65%54M | -75.00%3M | 900.00%10M | 1,150.00%25M | 750.00%17M | -32.00%17M | 1,300.00%12M |
| Net other financing activities | -75.62%306M | 1,166.67%76M | 1,285.71%83M | 145.50%96M | -23,060.00%-1.16B | 25,200.00%1.26B | 250.00%6M | 96.45%-7M | -904.76%-211M | 16.67%-5M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -82.77%189M | 156.44%114M | 40.79%-164M | 80.16%-175M | -261.18%-793M | 403.21%1.1B | -23.93%-202M | 80.62%-277M | -302.76%-882M | -8.72%492M |
| Net cash flow | ||||||||||
| Beginning cash position | 501.85%325M | 86.24%203M | -11.54%92M | 62.50%104M | 1,398.08%779M | -27.03%54M | 14.74%109M | 62.50%104M | -23.81%64M | -65.33%52M |
| Current changes in cash | -127.86%-202M | 321.82%122M | 2,120.00%111M | -130.00%-12M | -1,421.15%-687M | 3,395.45%725M | -161.90%-55M | -83.87%5M | 273.91%40M | 161.18%52M |
| End cash Position | -84.21%123M | 501.85%325M | 86.24%203M | -11.54%92M | -11.54%92M | 1,398.08%779M | -27.03%54M | 14.74%109M | 62.50%104M | 62.50%104M |
| Free cash from | -0.52%-388M | -93.88%9M | -1.78%276M | -16.29%149M | 193.86%107M | -60.17%-386M | 2.80%147M | -27.95%281M | 142.48%178M | 81.70%-114M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.